Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Siemens Healthcare and...

    Siemens Healthcare and Thermo Fisher Announce Strategic Relationship in Molecular Testing

    Written by savita thakur thakur Published On 2016-04-08T14:29:35+05:30  |  Updated On 8 April 2016 2:29 PM IST
    Siemens Healthcare and Thermo Fisher Announce Strategic Relationship in Molecular Testing

    Amsterdam : In a joint effort to provide customers with one of the most advanced solutions for molecular testing, Siemens Healthcare and Thermo Fisher Scientific announce a new strategic relationship that includes the integration of Thermo Fisher Scientific’s real-time PCR system into Siemens’ VERSANT® kPCR Molecular Solution. The combined workflow will offer laboratories Siemens’ complete molecular testing solution, which helps ensure leading-edge performance from extraction through detection. Siemens will display the entire system during the European Congress of Clinical Microbiology and Infectious Disease in Amsterdam, The Netherlands, April 9-12.


    Thermo Fisher has brought to market easy-to-use, real-time PCR instruments. Designed for mid-throughput, these new systems provide ideal solutions for all users who need a high-performance instrument with features for maximum experiment control. Adding Thermo Fisher’s real-time PCR system to the VERSANT kPCR Molecular Solution brings a new level of innovation to the market by providing more flexibility and customization to the molecular laboratory workflow.


    “Through our molecular diagnostics systems, we offer a total solution for accurate diagnosis and monitoring,” says Fernando Beils, Head of Molecular Diagnostics, Siemens Healthcare. “We are excited to strengthen our dedication to molecular laboratory innovations through our partnership with Thermo Fisher Scientific.”


    “This agreement underscores our commitment to work with leading molecular diagnostic organizations that share our vision to develop advanced laboratory solutions,” said Drew Burch, Head of Licensing and Commercial Supply for Thermo Fisher Scientific. “We are excited to collaborate with Siemens in support of its VERSANT kPCR Molecular Solution as we work to expand our partnerships in the diagnostics space.”


    Stop by Siemens’ booth 51 and Thermo Fisher’s booth 67a at ECCMID to learn more.


    VERSANT is a trademark of Siemens Healthcare Diagnostics Inc. or its affiliates. All other trademarks are properties of their respective owners. Product availability varies by country.

    Drew BurchEuropean Congress of Clinical MicrobiologyInfectious DiseaseMolecular DiagnosticsSiemensSiemens HealthcareThermo Fisher
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok